Reading the Numbers Honestly: The Full Specification Table With the evidence framed, here is the detailed side-by-side specification
Protocol approach 2: gut-focused autoimmune support (BPC-157 plus KPV) Goal: Restore gut barrier integrity and reduce intestinal inflammation Components: BPC-157 : 200-300 mcg twice daily, orally or subcutaneously near the abdomen (promotes mucosal healing, angiogenesis) KPV: 200-500 mcg daily, orally (NF-kB inhibition, cytokine reduction, PepT1-mediated gut absorption) Rationale: For autoimmune conditions with significant gastrointestinal involvement, including IBD, celiac-associated inflammation, or any autoimmune condition complicated by leaky gut, this combination addresses both the physical barrier damage (BPC-157) and the inflammatory signaling (KPV)
No, neither peptide is approved for general therapeutic use
A dose administered during the course of the day promotes improved sleep on the subsequent night and for several nights thereafter a temporal profile incompatible with direct sedation and consistent with a neuromodulatory mechanism acting on sleep homeostatic systems
The peptide cost calculator can help estimate the ongoing expense of maintaining this dual-peptide protocol
As, el motivo impulsa la migracin endotelial, la adhesin celular y el brote vascular (angiognesis) (FASEB J 2003
